Precision screening identifies mitoxantrone as a multitarget inhibitor in ageing-associated cancers with extensive computational validation and doxorubicin comparison
Fig 5
The figure shows the Density Functional Theory (DFT) Results of the identified compound Mitoxantrone, where the relative energy is shown along with all other energies.